Overexpression of RhoE has a prognostic value in non-small cell lung cancer

Annals of Surgical Oncology

Volumn 14, Issue 9, 2007, Pages 2628-2635

  Zhang, Cuiyan ^a   Zhou, Fang ^a   Li, Ning ^a   Shi, Susheng ^a   Feng, Xiaoli ^a   Chen, Zhaoli ^a   Hang, Jie ^a   Qiu, Bin ^a   Li, Baozhong ^a   Chang, Sheng ^b   Wan, Junting ^a   Shao, Kang ^a   Xing, Xuezhong ^a   Tan, Xiaogang ^a   Wang, Zhen ^a   Xiong, Meihua ^a   He, Jie ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Non small cell lung cancer; Prognosis; RhoE

Indexed keywords

PROTEIN RHOE; RHO FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DEMOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RHO GTP-BINDING PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 34548547220     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9457-x     Document Type: Article

References (25)

1. Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005 cancer. Cancer Epidemiol Biomarkers Prev 2005;14:243-50
2. Yang L, Parkin DM, Li LD, et al. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 2004;90:2157-66
3. Yoshioka K, Nakamori S, Itoh K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res 1999;59:2004-10
4. Pille JY, Denoyelle C, Varet J, et al. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 2005;11:267-74
5. Liu N, Bi F, Pan YL, et al. The expression and possible function of RhoA in human gastric cancer cell lines. Zhonghua Zhong Liu Za Zhi 2004;26:26-9
6. Kamai T, Yamanishi T, Shirataki H, et al. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 2004;10:4799-805
7. Kamai T, Kawakami S, Koga F, et al. RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int 2003;91:234-8
8. Horiuchi A, Imai T, Wang C, et al. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 2003;83:861-70
9. Yao H, Dashner EJ, van Golen CM, et al. RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility. Oncogene 2006;25:2285-96
10. Shikada Y, Yoshino I, Okamoto T, et al. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma. Clin Cancer Res 2003;9:5282-6
11. Kleer CG, van Golen KL, Zhang Y, et al. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 2002;160:579-84
12. Kleer CG, Griffith KA, Sabel MS, et al. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Res Treat 2005;93:101-10
13. Ikoma T, Takahashi T, Nagano S, et al. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice. Clin Cancer Res 2004;10:1192-200
14. Bellovin DI, Simpson KJ, Danilov T, et al. Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma. Oncogene 2006;25:6959-67
15. Han ZQ, Zhang AL, Wu MF, et al. Correlation of expression of RhoA, RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro. Zhonghua Zhong Liu Za Zhi 2004;26:385-8
16. Adnane J, Muro-Cacho C, Mathews L, et al. Suppression of rho B expression in invasive carcinoma from head and neck cancer patients. Clin Cancer Res 2002;8:2225-32
17. Mazieres J, Antonia T, Daste G, et al. Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 2004;10:2742-50
18. Foster R, Hu KQ, Lu Y, et al. Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation. Mol Cell Biol 1996;16:2689-99
19. Guasch RM, Scambler P, Jones GE, et al. RhoE regulates actin cytoskeleton organization and cell migration. Mol Cell Biol 1998;18:4761-71
20. Zhang CY, Hang J, Zhou F, et al. Overexpression of RhoE in non-small cell lung cancer (NSCLC) is associated with smoking and correlates with DNA copy number changes. Cancer Biol Ther 2007;6:335-42
21. Kallioniemi OP, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001;10:657-62
22. Trojan L, Schaaf A, Steidler A, et al. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res 2005;25:183-91
23. Villalonga P, Guasch RM, Riento K, et al. RhoE inhibits cell cycle progression and Ras-induced transformation. Mol Cell Biol 2004;24:7829-40
24. Bektic J, Pfeil K, Berger AP, et al. Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis. Prostate 2005;64:1-9
25. Lokeshwar VB, Cerwinka WH, Isoyama T, et al. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor. Cancer Res 2005;65:7782-9